The following tender has just been released by DoHA
ePrescribing and Dispensing of Medicines Benefits Realisation and Implementation Plan
The purpose of this consultancy is to:
1. Identify options for a nation-wide ePrescribing system.
2. Analyse all options and recommend an optimum ePrescribing system.
3. Produce a full Business Case for the preferred ePrescribing system.
4. Provide a Final Report on all activities - the ePrescribing andDispensing of Medicines Benefits Realisation and Implementation Plan.
The consultant must consider these objectives in the context of:
- the findings of the KPMG Report 'Consultancy in Electronic Prescribing and Dispensing of Medicines (ePrescribing), June 2008';
- a consumer centred approach;
- the preservation and protection of the PBS;
- PBS and non PBS medicines;
- different prescribing settings, for example general practice, residential aged care facilities and acute care;
- current jurisdictional and industry initiatives;
- maximising the effectiveness and efficiency of existing infrastructure;
- the current and future medication management packages, terminology standards and other relevant information from NEHTA;
- privacy, consent and security requirements;
- any required legislative or regulatory changes; and
- the availability of data to inform National Medications Policy decisions.
Details and the tender can be found here:
It is not often one sees a more dramatic example of the bureaucracy ‘closing the stable door after the horse has bolted’!
The context for the development of the plan is fascinating.
“The ePrescribing Plan will need to be developed with regard to:
· the National E-Health Strategy (December 2008);
· industry initiatives;
· the KPMG Report. This report identified that there were potential benefits from the longer term implementation of national ePrescribing and dispensing of medicines that results from the availability of data to support National Medicines Policy (NMP). This tender process seeks to appoint a consultant to addresses the recommendations of the report, which were:
Recommendation 1: That the business case defining the high level, long term costs and benefits for the development of the ePrescribing framework is undertaken.
Recommendation 2: Rather than the identification of specific road testing scenarios, it is recommended that road testing be undertaken within the context of the wider ePrescribing strategic directions described in this report.
Recommendation 3: That the Department undertake a review of options for governance and ownership arrangements for ePrescribing support systems and, separately, for the stewardship of transaction data and information content.
Recommendation 4: That consideration be given to the development of specifications required for enhanced claiming, audit and compliance practices which ensure the integrity of the PBS Program under an ePrescribing environment.
· the National E-Health Transition Authority (NEHTA) work program on eMedication Management and broader building blocks for eHealth. Some of these building blocks are healthcare provider and individual identifiers, identity management, clinical information and terminologies and secure messaging. Any national approach needs to adopt these technical standards and consider the broader eHealth environment.
· the links between ePrescribing and other initiatives that improve the quality and safety of healthcare delivery including the National Medicines Policy (NMP) and Quality Use of Medicines (QUM) initiatives. The potential relationship between ePrescribing systems and QUM principles and a patient centred approach needs to be considered.
· the interest and respective roles of the Commonwealth in administering the PBS as the largest procurer of medicines in Australia and all relevant stakeholders.
Just what sort of view do the bureaucrats imagine the consultants will form regarding industry initiatives and how will these be aligned with public expectation for governance and so on – cited in Recommendation 3 and NEHTA’s work!
This will be quite a challenge indeed!
What is more amazing is that the tender suggesst that the study will take about 34 weeks – not at all unreasonable – but that a key outcome will be that “ ePrescribing and dispensing outcomes to be delivered by the year 2014”
It seems no one is in any hurry here at all!
Can I say what we have is an out of touch and clueless DoHA, caught seriously short by some industry players, playing a just pathetic game of catch-up. A joke!